BioLargo Provides 2024 Review and 2025 Outlook
BioLargo, Inc. (OTCQX:BLGO), a company that creates and commercializes sustainable technologies to solve tough environmental and cleantech challenges, is pleased to provide a recap of its successful ...
Model output · Signal date 2026-10-13
Biolargo, Inc. (BLGO) Stock Forecast Oct. 13, 2026
Analysis updated on Oct. 13, 2026 (UTC) · Alpha · vs marketSwitch to Total · OTC
Rating · 90D
▲ Bullish
Exact rating locked
90-day forecast
Sign up free to reveal
30-day forecast
Alpha
Rank in coverage
Top 35%
of 5379 stocks scored
Rank correlation · 90D
n/a
No per-ticker sample yet
Market Cap
$25M
small-cap · #14 of 15 peers
Summary
Biolargo, Inc. (BLGO) stock forecast summary
Our AI ranks Biolargo, Inc. outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.
Biolargo, Inc. is a small-cap company with a market capitalization of $25M. It ranks number 14 by market capitalization among the 15 Chemicals & Allied Products issuers in our coverage with a current forecast.
A per-ticker accuracy statistic for BLGO is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Expected return relative to the market over the horizon: a positive alpha means the model expects the stock to beat the market, whatever the market does. Ratings: strong buy ≥ +1.3%, buy ≥ +0.5%, sell < -0.5%, strong sell < -1.6% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-10-13 signals)
A free account shows the exact forecast, rating and rank of 3 tickers you follow, BLGO included.
Follow BLGO freePrice
BLGO price chart and AI forecast
Cross-section · 2026-10-13
How BLGO ranks among 5379 stocks
90D Alpha forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
Fundamentals
Biolargo, Inc. (BLGO) fundamentals
Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Chemicals & Allied Products peers listed below that report each metric.
Valuation & Market
| Metric | BLGO | Rank |
|---|---|---|
| Market Cap | $25M | 14/15 |
| Revenue/Share | $0.01 | – |
Profitability & Margins
| Metric | BLGO | Rank |
|---|---|---|
| ROA | -234.7% | 13/13 |
| Gross Margin | 45.3% | 3/14 |
| Operating Margin | -504.1% | 11/13 |
| Net Margin | -435.5% | 11/13 |
| EBT Margin | -513.8% | 13/14 |
| Tax Rate | 0.0% | – |
Financial Health
| Metric | BLGO | Rank |
|---|---|---|
| Current Ratio | 0.73x | 13/14 |
| Quick Ratio | 0.67x | 13/13 |
| Interest Coverage | -13.1x | 9/14 |
| Working Capital | -$1M | 14/14 |
Cash Flow
| Metric | BLGO | Rank |
|---|---|---|
| Operating Cash Flow | -$13M | 15/15 |
Operational Efficiency
| Metric | BLGO | Rank |
|---|---|---|
| Asset Turnover | 0.61x | 7/13 |
| Receivables Turnover | 5.6x | 6/10 |
| Inventory Turnover | 8.1x | 3/13 |
| Fixed Assets Turnover | 2.3x | 8/13 |
| Days Sales Outstanding | 65 days | 5/10 |
| Days Inventory | 45 days | 11/13 |
| Payables Period | 130 days | 2/10 |
| Cash Conversion Cycle | -20 days | 6/7 |
Income Statement
| Metric | BLGO | Rank |
|---|---|---|
| Total Revenue | $4M | 10/13 |
| Operating Income | -$18M | 9/13 |
| Net Income | -$15M | 5/13 |
| R&D Expense | $3M | 8/10 |
| SG&A Expense | $13M | 11/13 |
| Cost of Goods Sold | $2M | 12/14 |
Dividend & Shareholder Information
| Metric | BLGO | Rank |
|---|---|---|
| Shares Outstanding | 329M | – |
Balance Sheet Highlights (USD millions)
| Total Current Assets | $4M | |
| Cash & Short-term Investments | $2M | |
| Accounts Receivable | $720K | |
| Inventory | $300K | |
| Total Liabilities | $9M | |
| Short-term Debt | $4M |
Quarterly Financial Reports
BLGO quarterly financials and insider trading
Industry Peers · Chemicals & Allied Products
Biolargo, Inc. (BLGO) industry peers
Companies classified under the same SEC industry code as Biolargo, Inc. (Chemicals & Allied Products): 17 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.
Reveal all forecasts · See exact % predictions for all competitors
Sign up free| Company | 90-Day AI Forecast (Alpha) | Market Cap |
|---|---|---|
| BLGO Biolargo, Inc. | ▲ | $25M |
| BCPC Balchem Corp | ▼ | $5.41B |
| PRM Perimeter Solutions, Inc. | ▲ | $4.50B |
| NGVT Ingevity Corp | ▶ | $2.41B |
| IOSP Innospec Inc. | ▼ | $2.40B |
| CC Chemours Co | ▼ | $1.99B |
| OLN Olin Corp | ▶ | $1.69B |
| HUN Huntsman Corp | ▶ | $1.43B |
| ECVT Ecovyst Inc. | ▲ | $1.09B |
| FMC Fmc Corp | ▶ | $1.04B |
| SLI Standard Lithium Ltd. | ▼ | $357M |
| ADUR Aduro Clean Technologies Inc. | ▶ | $307M |
| ACNT Ascent Industries Co. | ▲ | $122M |
| LQMT Liquidmetal Technologies Inc | ▼ | $84M |
| GURE Gulf Resources, Inc. | ▶ | $6M |
| CITR Citrotech Inc. | ▶ | N/A |
| LOOP Loop Industries, Inc. | ▶ | N/A |
Where BLGO sits on the market map
Industrial Applications and Services · Chemicals & Allied Products
News
Biolargo, Inc. (BLGO) stock news
BioLargo, Inc. (BLGO) Q4 2025 Earnings Call Transcript
Good afternoon, everyone, and thank you for your patience. Welcome to the BioLargo 2025 Annual Report and Earnings Call. [Operator Instructions] Please note, this conference is being recorded. I will ...
BioLargo, Inc. to Present at the Inaugural Nasdaq / LD Micro Summit on September 9, 2026
WESTMINSTER, CA / ACCESS Newswire / September 1, 2026 / BioLargo, Inc. (OTCQX:BLGO), a cleantech and life sciences innovator and engineering services solution provider, today announced that Dennis P.
FAQ
Biolargo, Inc. (BLGO) stock forecast FAQ
What is the Biolargo, Inc. (BLGO) stock forecast?
Our AI ranks Biolargo, Inc. outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.
How accurate are Biolargo, Inc. stock predictions?
A per-ticker accuracy statistic for BLGO is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
How often are Biolargo, Inc. forecasts updated?
Biolargo, Inc. forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Oct. 13, 2026.
Which companies are Biolargo, Inc.'s industry peers?
17 issuers in our coverage, BLGO included, share the SEC industry code Chemicals & Allied Products. The largest are: Balchem Corp (BCPC), Perimeter Solutions, Inc. (PRM), Ingevity Corp (NGVT), Innospec Inc. (IOSP), Chemours Co (CC), Olin Corp (OLN).
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.